SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation.

Cesarina Giallongo; Piera La Cava; Daniele Tibullo; Ignazio Barbagallo; Nunziatina Parrinello; Alessandra Cupri; Fabio Stagno; Carla Consoli; Annalisa Chiarenza; Giuseppe A Palumbo

doi:10.1186/1471-2407-13-60

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation.

Identifier:nobleid.org/w1/20260515/AC29396C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AC29396C.svg?ark=w1%2F20260515%2FAC29396C)](https://nobleid.org/work/w1/20260515/AC29396C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Nunziatina Parrinello

Claim authorship of this work

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation.

Identifier:nobleid.org/w1/20260515/AC29396C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AC29396C.svg?ark=w1%2F20260515%2FAC29396C)](https://nobleid.org/work/w1/20260515/AC29396C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Nunziatina Parrinello

Claim authorship of this work